Terveystieteiden and dissolution behaviour of amorphous drugs. In previous studies, however these mixtures have been 23 produced mainly with small-scale preparation methods, or with methods that have required the use 24 of organic solvents or other dissolution enhancers. In the present study, co-amorphous ibuprofen-25 arginine and indomethacin-arginine mixtures were spray dried from water. The mixtures were 26 prepared at two drug-arginine molar ratios (1:1 and 1:2). The properties of the prepared mixtures 27
INTRODUCTION 42
If orally administered drugs are to be bioavailable, they have to possess sufficient water solubility. 43
For some drugs (Biopharmaceutical classification system; Class II), the dissolution may even be the 44 rate limiting step in drug absorption (Baghel et al. 2016 ). However, since the advent of combinatorial 45 chemistry and high throughput screening techniques, the water solubility of new drug candidates has 46 decreased drastically (Lipinski et al. 2001) . 47
Utilizing the amorphous form of a drug is one of the numerous formulation methods intended to 48 improve its dissolution properties (Laitinen et al. 2013 ). The increase in apparent solubility and hence 49 bioavailability, is due to the higher internal energy in the amorphous form compared to the crystalline 50 counterpart. On the other hand, this property may cause the amorphous drug to recrystallize during 51 processing, storage, or dissolution. Nevertheless, it is now well established that with a proper 52 selection of a polymer, the polymeric amorphous solid dispersion approach may improve the solid-53 state stability of the amorphous form as well as increase the stability of the supersaturated state in a 54 solution (Baghel et al. 2016 ; He and Ho 2015) . Despite intensive research, however, only a few 55 amorphous solid dispersion based formulations have reached the global market (He and Ho 2015) . 56
There are several challenges associated with these polymers e.g. the poor miscibility of some drugs 57 with polymers, the hygroscopicity of polymers, incompatibility issues, and other poor formulation 58 characteristics, such as poor flowability or compressibility (Löbmann et al. 2011) . 59
In an attempt to avoid the use of polymers, another subclass of solid dispersions, namely co-60 amorphous formulations, has been introduced (Dengale et al. 2016; Laitinen et al. 2013 ). In co-61 amorphous formulations, low molecular weight compounds are used instead of polymers to form an 62 amorphous homogenous single-phase mixture (Dengale et al. 2016) . In order to prepare co-63 amorphous systems, both pharmaceutically active substances and inactive excipients have been used, 64 and both approaches have successfully stabilized the amorphous form and enhanced the dissolution 65 In spray drying, a solution containing the solvent and the components of the co-amorphous mixture 83 is sprayed into a hot air stream, with the rapid evaporation of the solvent, and the formation of 84 homogenous amorphous solid particles (Vasconcelos et al. 2016 ). Additional advantages of spray 85 drying against melting methods include the relatively low processing temperatures and beneficial 86 particle morphology (Baghel et al. 2016 ). The challenge in the preparation of co-amorphous 87 formulations via spray drying is to find a common solvent suitable for all the components, especially 88 when combining a poorly water-soluble drug with a readily-soluble co-former. Since it is important 89 to avoid the use of toxic and environmentally hazardous organic solvents, excipients, such as 90 surfactants may be needed to enhance the dissolution of the drug, and subsequently to enable the 91 spray drying (Craye et al. 2015) . However, some tolerability issues may also be associated with the 92 surfactants (Baghel et al. 2016 ). Thus, it would be preferable to find co-formers that alone would 93 enhance the dissolution of the drug adequately to enable the spray drying from aqueous solutions 94 containing only the co-former and the drug. 95
In the present study, co-amorphous mixtures of arginine (ARG) with ibuprofen (IBU) and 96 indomethacin (IND) were prepared by spray drying. Unlike in the previous studies investigating spray 97 drying co-amorphous formulations, only pure water was used as a solvent in order to avoid the 98 properties of the mixtures were studied in 24h dissolution tests. 106
MATERIALS AND METHODS 107

Materials 108
IND was purchased from Hangzhou Dayanchem (Hangzhou, China), ARG from Sigma-Aldrich 109 (Riedel-de Haan, Germany), and IBU was kindly donated by Orion Pharma (Espoo, Finland) (see 110 Figure 1 for chemical structures). Sodium chloride (NaCl; J.T. Baker, Deventer, Holland), 111 hydrochloric acid (HCl, 37 %; Riedel-de-Haën, Seelze, Germany), potassium dihydrogen phosphate 112 (KH2PO4; Merck, Darmstadt, Germany), sodium hydroxide (NaOH; VWR Chemicals, Leuven, 113 Belgium), and glacial acetic acid (Riedel de Haën, Germany) were used to prepare the buffer solutions 114 (pH 1.2, 5.0 and 7.2). Phosphorus pentoxide (P2O5) was used to maintain 0% and sodium bromide 115 (NaBr) to ensure 60% relative humidity (RH) conditions during storage. 116
Purified (class II; Elix 5, Millipore S.A.S., Molsheim, France) and ultrapurified (class I; Elga Purelab 117 Ultra, Elga LabWater, UK) water were used throughout the study. If not specified, class II water was 118 used. Acetonitrile (ACN; HiPerSolv for HPLC, VWR Chemicals, Leuven, Belgium) and trifluoro 119 acetic acid (TFA, 55.5%; HPLC grade, Alfa Aesar, Karlsruhe, Germany) were used as components 120 of the high performance liquid chromatography (HPLC) mobile phase. 121
Methods 122
Phase solubility test 123
To explore the effect of the ARG concentration on the solubilities of the model drugs, we added an 124 excess of both drugs to 20 ml of 1%, 5% and 10% (m/V) ARG-water solution. The study was 125 performed in triplicate in 50 ml Erlenmeyer flasks containing a magnetic stirrer bar (ambient 126 conditions). After 3 days of stirring, a 5 ml sample from each flask was filtered through 0.22 µm 127 membrane filter (Syringe Filter 30 mm Dia, PES 0.22 µm Membrane, Sterile, Porvair Sciences), and 128 the filtrate was diluted with an adequate amount of 70/30 (V/V) ACN/class I water-mixture to reach 129 concentrations between 1 and 100 µg/ml. 130
High Performance Liquid Chromatography (HPLC) 131
The drug concentrations were measured in an HPLC that consisted of Gilson 321 pump, Gilson UV-132 vis 151 detector (both from Gilson Inc., Middleton, WI, USA), Gilson 234 auto injector (Gilson, 133
Roissy-en-France, France), and a reversed phase column (Phenomenex Gemini NX 5u C18 110A, 134 250x4, 60 mm, sr. nr. 590531-19, USA) with a pre-column. The mobile phase flow rate was set at 135 1.2 ml/min and the detection wavelengths were 221 nm for IBU and 225 nm for IND. The mobile 136 phase consisted of 70% of ACN and 30% of class I water, which were acidified by addition of 0.1% 137 of TFA. 138
We prepared a 100 µg/ml standard solution from both drugs by weighing 10 mg of drug and 139 dissolving it into 100 ml of 70/30 ACN/class I water-mixture. Other standard solutions (1, 5, 12.5, 140 25, 50 µg/ml) were prepared by diluting the 100 µg/ml solution. Each standard solution was analysed 141 by HPLC to obtain standard lines that were found to be linear (R 2 > 0.997) in the examined 142 concentration range. 143
Spray drying 144
Spray drying was conducted with a Büchi Mini Spray Dryer B-191 (Büchi Labortechnik AG, Flawil, 145 Switzerland). The correct amount of crystalline drug was dissolved into 5 % (m/V) ARG-class 1 146
water-solution to achieve drug-ARG-molar ratios of 1:1 or 1:2. When the drugs were completely 147 dissolved (no solid material left) the solutions were spray dried under following conditions: inlet 148 temperature 160 °C, outlet temperature 83 ± 6 °C, air flow rate 600 l/h, and pump rate 5.3 ± 0.2 149 ml/min. The correct molar ratios of the prepared powders were confirmed by completely dissolving 150 an amount of mixtures corresponding to 20 mg of the drugs and measuring the total amount of 151 dissolved drug by HPLC (see supplementary material; Table S1 ). 152
Cryomilling 153
Crystalline IND was converted into an amorphous form in an oscillatory ball mill (Mixer Mill 154 MM400, Retsch GmbH & Co., Haan, Germany). A total of 500 mg of crystalline drug was placed in 155 a 25 ml milling chamber with two 12 mm stainless steel balls. The chambers were immersed in liquid 156 nitrogen for two minutes prior to milling and every 10 minutes during the milling. The milling time 157
was 60 min at 30 Hz milling frequency. 158
Preparation of IBU-ARG salt by slowly evaporating water 159
To investigate whether a crystalline IBU-ARG salt could be produced by slowly evaporating the 160 solvent, 300 mg of IBU and a corresponding amount of ARG were dissolved in 5 ml of water to 161 produce IBU-ARG solutions of molar ratios of 1:1 and 1:2. Since the components had dissolved, the 162 solution was placed on a Petri dish, and the water was allowed to evaporate over 3 days in ambient 163 conditions in a fume hood. The resulting solid material was investigated with XRPD and FTIR. 164
Differential scanning calorimetry (DSC) 165
Thermal analyses were conducted using Mettler Toledo DSC823 e apparatus (Mettler-Toledo, 166
Schwerzenbach, Switzerland) equipped with an inter-cooler (Mettler-Toledo, METT-FT900 Julabo, 167 Switzerland) and an autosampler (TS080IRO Sample Robot, Mettler-Toledo, Schwerzenbach, 168 Switzerland). Thermograms were obtained under a nitrogen gas flow (50 ml/min). Approximately 5 169 mg of sample powder was placed into a 40 µl aluminium pan, which was sealed with a pierced lid. 170
The temperature settings of the DSC runs for different materials can be found from the supplementary 171 material (Table S2) . For crystalline drugs, two heating cycles were performed to produce the pure 172 amorphous drug by in situ quench cooling, which enabled the measurement of melting temperature 173 (Tm) of crystalline drug (first cycle) and glass transition temperature (Tg) of amorphous drug (second 174 cycle). Spray dried samples were measured using temperature modulated DSC (TOPEM®, Mettler-175 Toledo, Schwerzenbach, Switzerland) to eliminate the effect of residual moisture. For crystalline 176 ARG, only one-cycle conventional DSC run was performed, since the production of amorphous ARG 177 via quench cooling has been shown to be impossible (Löbmann et al. 2013a) . 178
Theoretical Tg-values of the co-amorphous mixtures were calculated using Gordon-Taylor equation 179 (Eq. 1): 180
where Tg(mix) is the theoretical glass transition temperature of the mixture, w1 and w2 are the weight 181 fractions and Tg1 and Tg2 are the glass transition temperatures of the individual mixture components, 182 and K is a constant, which can by defined by Eq. 2: 183
where ρ1 and ρ2 are the densities of the two components. The densities of crystalline instead of 184 amorphous components were used as approximation. This approximation has been previously 185 justified by the small difference in powder densities between crystalline and amorphous small-186 molecular compounds (Löbmann et al. 2011; Löbmann et al. 2013a) . 187
Fourier transform infrared spectroscopy (FTIR) 188
FTIR-analyses were performed using Thermo Nicolet Nexus 8700 spectrometer (Thermo Electron 189
Corp., Madison, WI, USA) with attenuated total reflectance accessory. Average spectra of 64 scans 190 with the resolution of 4 cm -1 were collected over a wave number range of 650-4000 cm -1 . The results 191
were analyzed using Thermo Scientific OMNIC software (version 6.0a, Thermo Scientific). 192
X-ray powder diffraction (XRPD) 193
Bruker D8 Discover diffractometer (Bruker AXS GmbH, Karlsruhe, Germany) with Cu Κα radiation 194 
Stability studies 198
To investigate the stability of amorphous state in different conditions, the prepared amorphous 199 materials were kept under 4 °C/0% RH, 25 °C/60% RH, and 40 °C/0% RH. 0% RH was obtained by 200 using P2O5 and 60 % RH by using a saturated NaBr solution. To observe the changes in the solid 201 state, the materials were repeatedly analyzed with XRPD and FTIR. 202
Dissolution studies 203
Dissolution behavior of the materials was investigated with Sotax AT7 smart and Sotax 
Statistical analysis 214
The statistical analyses (single-factor ANOVA with Tukey's post-hoc test, linear regression) were 215 conducted with GraphPad Prism 5.03 (GraphPad Software Inc., La Jolla, USA). The results were 216 considered statistically significant if p < 0.05. 217
RESULTS AND DISCUSSION 218
Phase solubility test 219
The equilibrium solubilities of IBU and IND in 1, 5, and 10% (m/V) ARG solutions after 72h 220 solubility test are presented in Table 1 . The statistical analysis revealed significant differences in IBU 221 concentrations between 1 and 5% (m/V) ARG solutions, whereas the IND concentrations differed 222 significantly between every ARG solution. The linear regression analysis suggests that there was a 223 nearly linear increase (R 2 = 0.9522) in IND concentration as the ARG concentration was elevated. 224
With IBU, the linearity was less obvious (R 2 = 0.6950). 225
The effect of ARG concentration on IND solubility has been studied also by ElShaer et al. (2011) . 226
Although their study was conducted with smaller ARG concentrations (0.001-0.1% (m/V)), a linear 227 relationship between ARG and IND concentrations was observed. This linearity was attributed to the 228 total dissociation of IND in ARG solution, which promoted salt formation between these two species. 229
With IBU and ARG, we were unable to find phase solubility diagrams in the published literature, but 230 it has been shown that the IBU-ARG salt dissolved more rapidly when compared to the free acid 231 (Bruzzese and Ferrari 1981; Fini et al. 1985; Stroppolo et al. 1995) . Additionally, at low pH values, 232 the salt form seemed to maintain a higher cumulative amount dissolved at least for the first 500 233 minutes when compared to the free acid (Fini et al. 1985) . 234
Spray drying 235
Based on the phase solubility test, the 5% (m/V) ARG solution was chosen as the solvent for spray 236 drying co-amorphous drug-ARG mixtures, since it produced drug-ARG solutions of a molar ratio 237 close to 1:1 with both IBU and IND, and the solvent volumes remained relatively small, even with 238 increased batch sizes. Additionally, pure ARG was spray dried from a 5% solution. 239
Spray drying different drug-amino acid mixtures (from organic solutions) has previously resulted in 240
yields of approximately 70% (Jensen et al. 2016a ). In our study, the average yields with drug-ARG 241 mixtures varied from 29.2% to 34.4%. The lower yields may be attributed to different process 242 parameters (Lipiäinen et al. (2016) ), which were not further optimized, since a satisfactory amount 243 of material was produced to perform the desired analyses. Spray drying of pure ARG resulted in a 244 yield of only 3.5%, which was not unexpected based on the study of Lakio et al. (2015) , who failed 245 to spray dry pure ARG due to the hygroscopicity of the product, and the consequent lack of yield. 246
Despite the low yield also in the present study, enough material was produced to gain some insight 247 into the properties of the spray dried ARG. 248
Solid-state characterization 249
X-Ray Powder Diffraction 250
The halo patterns in the X-ray diffractograms (Figure 2 ) confirmed that all spray dried drug-ARG 251 mixtures as well as cryomilled IND were amorphous. With spray dried ARG, only minor peaks could 252 be observed at 2θ-values of approximately 18.2°, 19.0°, 22.9°, and 27.3°, evidence that the material 253 was mainly amorphous. However, the attempts to cryomill or quench cool pure IBU were 254 unsuccessful in producing amorphous IBU, as shown by the peaks characteristic for crystalline IBU 255 in Figure 2 . The instability of the amorphous IBU may be attributed to the very low Tg (Table 2) . At 256 ambient conditions, this leads to the rapid molecular movement and the consequent immediate 257 crystallization of IBU (Laitinen et al. 2013) . 258
We were unable to find previous attempts to produce amorphous IBU-ARG mixtures, but the 259 preparation of crystalline IBU-ARG salt has been introduced in U.S. In the situation that the amorphous form of the IBU-ARG mixture proves to be stable over a sufficient 272 time period, possesses improved dissolution properties when compared to crystalline IBU, and the 273 end product is in the form of IBU-ARG salt, the spray drying method described in the present study 274 may provide a viable option for the preparation methods in the cited patents. The benefits of this 275 method include the use of water as the sole solvent, the use of L-ARG instead of DL-ARG or D-276 ARG, and the production of dry powder ready for further processing through a single process step. 277
Additionally, less heat stress is directed to the drug when compared to the method in U.S. patent 278 5,463,117, since no melting of the drug is required. 279
The co-amorphous IND-ARG 1:1 mixture has been prepared previously by both cryomilling and 280 spray drying, and both preparation methods have been shown to produce stable co-amorphous 281 mixture with enhanced dissolution characteristics (Jensen et al. 2016a; Löbmann et al. 2013a) . 282
However, as far as we are aware, this is the first time that co-amorphous IND-ARG has been spray 283 dried from water, which minimizes the risk of residual organic solvents remaining in the final product. 284
Additionally, the production of amorphous ARG has been previously shown possible via freeze 285 drying (Izutsu et al. 2005 ), but according to the present study, spray drying may also result in at least 286 mainly amorphous ARG. Due to the low yields and some crystalline residues, this method, however 287 requires further adjustment, and may be only suitable for research purposes. 288
Differential Scanning Calorimetry 289
The co-amorphous mixtures exhibited a single Tg (Table 2, The Tgs of all the single components could be obtained from the cryomilled, quench cooled or spray 299 dried samples (Table 2, Figure S3 ). However, with spray dried ARG, the Tg was only visible with 300 one DSC sample, but the exothermic recrystallization peak (Trc (onset): 105 ± 0.3 °C) was observed 301 in non-reversing and total heat-flow plots of both of the measured samples. With IBU and IND, the 302
Tgs were consistent with the values previously reported, but with ARG, the deviation was more 303
pronounced. This phenomenon may be explained by the hygroscopicity and varying water content of 304 the amorphous ARG (Jensen et al. 2016b ). Based on their predictions, Jensen et al. suggested that 55 305 °C would be the most correct Tg for ARG, and that value was selected for Gordon-Taylor calculations 306 also in our study. 307
The
additivity of the components and the lack of interactions between them. In the present study, positive 311 deviations from predicted values were observed with both drug-ARG combinations at both molar 312 ratios (Table 2 ). In fact, the Tgs of the binary mixtures were higher than the Tg of either single 
Fourier-Transform Infrared Spectroscopy 325
The FTIR measurements were conducted to investigate the interactions between the drug and ARG, 326 which were assumed based on the DSC measurements. The wave number region from 1000 to 1800 327 cm -1 was evaluated, since the major differences in the spectra were observed in that region. The 328 spectra of the pure crystalline substances ( Figure S4 In the spectrum of spray dried ARG (Figure S4 ), the peaks were broader and less intense when 336 compared to crystalline ARG, which has been observed previously with amorphous material 337 . 2016a ), which to some extent could be attributed to 343 different molecular arrangements caused by different preparation methods. However, the reliability 344 of the spectrum of the freeze dried ARG seemed questionable due to the total disappearance of the 345 intense peaks of crystalline ARG between 1500 cm -1 and 1700 cm -1 . 346
The FTIR spectra of the co-amorphous IBU-ARG and IND-ARG mixtures (Figure 3 ) are presented 347 together with the calculated addition spectra of the corresponding drug and ARG. With IND-ARG, 348 the addition spectrum was formed using the spectra of amorphous components, but with IBU-ARG 349 the spectrum of crystalline IBU was used in the formation of the addition spectrum. This was 350 considered justified, however, due to the minor differences between the spectra of crystalline and 351
amorphous IBU (Kyeremateng et al. 2014). 352
The most significant change in the spectra of the co-amorphous mixtures of both molar ratios when 353 compared to the calculated addition spectra was the total disappearance of the carboxylic acid bands regardless of the preparation method, which was also observed with IND-ARG mixture in our 363 previous study (Ojarinta et al. 2017) . These interactions combined might explain the high Tgs observed also with the 1:2 co-amorphous 376 mixtures. 377
Stability studies 378
To investigate the solid-state stability of the co-amorphous mixtures, as well as comparing them to 379 the stability of the pure amorphous drugs, the materials were stored under three different conditions, 380 namely 4 °C, 0% RH; 25 °C, 60% RH; and 40 °C, 0% RH. However, at 25 °C, 60% RH condition, 381 both of the spray dried IBU-ARG mixtures and the spray dried IND-ARG 1:2 mixture transformed 382 into sticky liquids already before the first XRPD and FTIR measurements at day 7. This liquefaction 383 was due to the moisture absorbed by the hygroscopic amorphous material. With other material-384 condition combinations, the stability study was continued for one year, or until the first signs of 385 crystallization were observed in the X-ray diffractograms. The X-ray diffractograms and the FTIR 386 spectra at the end of the study are presented in Figure 4 . Additionally, the FTIR spectra remained unchanged when compared to the spectra recorded at day 0. 395 However, the appearance of many of the powders changed from a fine powder to a more sugar-like 396 form with larger particle size, and with some material-condition combinations, i.e. IND-ARG 1:1 in 397 25 °C, 60% RH and IBU-ARG 1:2 in 40 °C, 0% RH, the measurements could be performed only until 398 weeks 9 and 14, respectively, due to the increased stickiness of the powders. This change in 399 appearance was similar to that observed with some materials during the first week of the stability 400 study, and was attributed to the absorption of moisture either during the storage (25 °C, 60% RH) or 401 the measurements (40 °C, 0% RH). At a pH of 1.2, the cumulative dissolved amount of IBU (approximately 50% at 24h) from pure 444 crystalline powder remained lower when compared to the other formulations throughout the whole 445 experiment, and the difference was also statistically significant between the majority of the samples. 446
The impact of ARG on the dissolution of IBU was obvious, since the physical mixtures reached the 447 50% cumulative dissolved amount already before 2h (1:1 mixture) or 1h (1:2 mixture) time points, 448 and the total cumulative dissolved amount ranged from 74% (1:1 mixture) to 83% (1:2 mixture). 449
However, according to the statistical analysis, no significant difference was observed between the 450 two physical mixtures. In addition to the presence of ARG, the formation of a co-amorphous mixture 451 to the best of our knowledge, this is the first time that the dissolution properties of the IND-ARG 1:2 472 mixture have been studied. Somewhat surprisingly, the dissolution was even more rapid and more 473 complete with the molar ratio of 1:2 than with molar ratio of 1:1, which suggests that 1:1 salt 474 formation is not the only solubilizing interaction between IND and ARG. This suggestion is in 475 accordance with predictions based on our FTIR measurements. 476
As far as we are aware, the co-amorphous mixtures of IBU and ARG have not been prepared or 477 investigated previously. However, Fini et al. (1985) have studied the solubility of equimolar IBU-478 ARG salt, and found the higher dissolution rate when compared to the acid form of IBU especially at 479 low pH values. This could be predicted also based on the present study, since also the physical 480 mixtures increased the dissolution rate when compared to the pure crystalline IBU. Furthermore, the 481 difference between the dissolution profiles of the co-amorphous mixtures and the physical mixtures 482
was not as significant as with the IND-ARG mixtures, which might suggest that the salt formation 483 dominates the possible other solubilizing interactions between IBU and ARG during dissolution. 484
However, also with IBU-ARG, the co-amorphous mixture of molar ratio of 1:2 dissolved more 485 rapidly and more completely when compared to 1:1 mixture, which underlines the need for further 486 studies on the drug-ARG interactions in solution. at a pH of 1.2, the drugs remain unionized and poorly soluble, whereas at pH of 7.2, their dissolution 490 is enhanced due to almost complete ionization. Additionally, the pH dependence of the effect of ARG 491 on the dissolution of the drugs may be attributed to the differences in the ionization of the drugs 492 between the media of different pH. At higher pH values, the drugs were almost completely ionized 493 regardless of the presence of ARG, whereas at lower pH, the interactions (salt formation) between 494 acidic drug and basic ARG became significant. 495
The transit time through stomach and small intestine (main site for absorption) has been estimated to 496 be only less than 5h (Abuhelwa et al. 2016a; Yuen 2010). Thus, to ensure adequate absorption and 497 bioavailability, the drugs should dissolve already in the early parts of the small intestine. This rapid 498 dissolution may be challenging for acidic drugs, since the pH of the intestinal fluids is generally 499 lowest at the beginning of the gastrointestinal tract (Abuhelwa et al. 2016b). However, the elevated 500 dissolution rate and cumulative dissolved amount of IBU and IND from co-amorphous drug-ARG 501 mixtures in low pH conditions suggests that the formation of co-amorphous salt may be a potential 502 method in increasing the bioavailability of acidic drugs even though further studies are required. 503
CONCLUSIONS 504
The aim of the present study was to produce stable co-amorphous IBU-ARG and IND-ARG mixtures 505 with enhanced dissolution properties by spray drying from pure aqueous solutions. According to solid 506 state studies, the spray dried IBU-ARG and IND-ARG mixtures of molar ratios of 1:1 and 1:2 were 507 X-ray amorphous and possessed single Tg. Additionally, FTIR analysis revealed strong interactions 508 (e.g. salt formation) between both drugs and ARG. The physical stability of the co-amorphous 509 mixtures was significantly improved when compared to the pure amorphous drugs, although the 510 absorbance of moisture may cause handling difficulties especially with IBU-ARG mixtures. 511
Furthermore, at low pH, the co-amorphous mixtures dissolved more rapidly and more completely 512 when compared to the physical mixtures of the drug and ARG or to the pure drugs. This dissolution 513 enhancement might increase the amount of dissolved drug at the beginning of the gastrointestinal 514 tract, which again might improve bioavailability. In conclusion, spray drying seems to be a potential 515 up-scalable method for preparing co-amorphous mixtures that possess improved physical stability 516 and dissolution characteristics. Additionally, the use of organic solvents and surfactants may be 517 avoided if the appropriate co-former solubilizes the drug adequately. 518 
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